The Endocrinology of Human Pregnancy and Fetoplacental Neuroendocrine Development

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 249-281

  Mesiano, Sam ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883947709     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00011-5     Document Type: Chapter

References (388)

1. Wilcox A.J., Baird D.D., Weinberg C.R. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999, 340:1796.
2. Nikas G. Endometrial receptivity: changes in cell-surface morphology. Semin Reprod Med 2000, 18:229.
3. Gipson I.K., Blalock T., Tisdale A., et al. MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol Reprod 2007.
4. Kao L.C., Tulac S., Lobo S., et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143:2119.
5. Giudice L.C. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 1994, 61:1.
6. Eun Kwon H., Taylor H.S. The role of HOX genes in human implantation. Ann N Y Acad Sci 2004, 1034:1.
7. Taylor H.S. The role of HOX genes in human implantation. Hum Reprod Update 2000, 6:75.
8. Bagot C.N., Kliman H.J., Taylor H.S. Maternal HOXA10 is required for pinopod formation in the development of mouse uterine receptivity to embryo implantation. Dev Dyn 2001, 222:538.
9. Cermik D., Karaca M., Taylor H.S. HOXA10 expression is repressed by progesterone in the myometrium: differential tissue-specific regulation of HOX gene expression in the reproductive tract. J Clin Endocrinol Metab 2001, 86:3387.
10. Morton H., Cavanagh A.C., Athanasas-Platsis S., et al. Early pregnancy factor has immunosuppressive and growth factor properties. Reprod Fertil Dev 1992, 4:411.
11. Punnonen R., Lukola A. Binding of estrogen and progestin in the human fallopian tube. Fertil Steril 1981, 36:610.
12. Cross J.C., Werb Z., Fisher S.J. Implantation and the placenta: key pieces of the development puzzle. Science 1994, 266:1508.
13. Paria B.C., Reese J., Das S.K., et al. Deciphering the cross-talk of implantation: advances and challenges. Science 2002, 296:2185.
14. Strowitzki T., Germeyer A., Popovici R., et al. The human endometrium as a fertility-determining factor. Hum Reprod Update 2006, 12:617.
15. Loke Y.W., King A., Burrows T.D. Decidua in human implantation. Hum Reprod 1995, 10(Suppl 2):14.
16. King A., Jokhi P.P., Burrows T.D., et al. Functions of human decidual NK cells. Am J Reprod Immunol 1996, 35:258.
17. Bigazzi M., Pollicino G., Nardi E. Is human decidua a specialized endocrine organ?. J Clin Endocrinol Metab 1979, 49:847.
18. Golander A., Hurley T., Barrett J., et al. Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science 1978, 202:311.
19. Riddick D.H., Kusmik W.F. Decidua: a possible source of amniotic fluid prolactin. Am J Obstet Gynecol 1977, 127:187.
20. Riddick D.H., Luciano A.A., Kusmik W.F., et al. De novo synthesis of prolactin by human decidua. Life Sci 1978, 23:1913.
21. Bryant-Greenwood G.D. Relaxin as a new hormone. Endocr Rev 1982, 3:62.
22. Hirst J.J., Mijovic J.E., Zakar T., et al. Prostaglandin endoperoxide H synthase-1 and -2 mRNA levels and enzyme activity in human decidua at term labor. J Soc Gynecol Investig 1998, 5:13.
23. Kredentser J.V., Embree J.E., McCoshen J.A. Prostaglandin F2 alpha output by amnion-chorion-decidua: relationship with labor and prostaglandin E2 concentration at the amniotic surface. Am J Obstet Gynecol 1995, 173:199.
24. Damsky C.H., Fisher S.J. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr Opin Cell Biol 1998, 10:660.
25. Geva E., Ginzinger D.G., Zaloudek C.J., et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002, 87:4213.
26. Sharkey A.M., Charnock-Jones D.S., Boocock C.A., et al. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993, 99:609.
27. Jackson D., Volpert O.V., Bouck N., et al. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 1994, 266:1581.
28. Linzer D.I., Fisher S.J. The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol Endocrinol 1999, 13:837.
29. Khong T.Y., De Wolf F., Robertson W.B., et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986, 93:1049.
30. King A., Hiby S.E., Gardner L., et al. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors: a review. Placenta 2000, 21(Suppl A). S81.
31. Le-Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans 2000, 28:208.
32. Jerzak M., Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling. Eur J Obstet Gynecol Reprod Biol 2002, 100:138.
33. Waddell B.J. The placenta as hypothalamus and pituitary: possible impact on maternal and fetal adrenal function. Reprod Fertil Dev 1993, 5:479.
34. Petraglia F., Florio P., Nappi C., et al. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 1996, 17:156.
35. Csapo A.I., Pulkkinen M.O., Wiest W.G. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973, 115:759.
36. Jaffe R.B., Lee P.A., Midgley A.R. Serum gonadotropins before, at the inception of, and following human pregnancy. J Clin Endocrinol Metab 1969, 29:1281.
37. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993, 68:495.
38. Nisula B.C., Morgan F.J., Canfield R.E. Evidence that chorionic gonadotropin has intrinsic thyrotropic activity. Biochem Biophys Res Commun 1974, 59:86.
39. Carayon P., Lefort G., Nisula B. Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes. Endocrinology 1907, 106:1980.
40. Pekonen F., Weintraub B.D. Interaction of crude and pure chorionic gonadotropin with the thyrotropin receptor. J Clin Endocrinol Metab 1980, 50:280.
41. Carayon P., Amr S., Nisula B., et al. Effect of carboxypeptidase digestion of the human choriogonadotropin molecule on its thyrotropic activity. Endocrinology 1981, 108:1891.
42. Jaffe R.B., Seron-Ferre M., Huhtaniemi I., et al. Regulation of the primate fetal adrenal gland and testis in vitro and in vivo. J Steroid Biochem 1977, 8:479.
43. Seron-Ferre M., Lawrence C.C., Jaffe R.B. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 1978, 46:834.
44. Huhtaniemi I.T., Korenbrot C.C., Jaffe R.B. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1977, 44:963.
45. Quagliarello J., Goldsmith L., Steinetz B., et al. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin. J Clin Endocrinol Metab 1980, 51:74.
46. Licht P., Fluhr H., Neuwinger J., et al. Is human chorionic gonadotropin directly involved in the regulation of human implantation?. Mol Cell Endocrinol 2007, 269:85.
47. Toth P., Li X., Lei Z.M., et al. Expression of human chorionic gonadotropin (hCG)/luteinizing hormone receptors and regulation of the cyclooxygenase-1 gene by exogenous hCG in human fetal membranes. J Clin Endocrinol Metab 1996, 81:1283.
48. Slattery M.M., Brennan C., O'Leary M.J., et al. Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility. BJOG 2001, 108:704.
49. Belmonte A., Ticconi C., Dolci S., et al. Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin. J Soc Gynecol Invest 2005, 12:570.
50. Kasahara K., Takakura K., Takebayashi K., et al. The role of human chorionic gonadotropin on decidualization of endometrial stromal cells in vitro. J Clin Endocrinol Metab 2001, 86:1281.
51. Nemansky M., Moy E., Lyons C.D., et al. Human endometrial stromal cells generate uncombined alpha-subunit from human chorionic gonadotropin, which can synergize with progesterone to induce decidualization. J Clin Endocrinol Metab 1998, 83:575.
52. Huhtaniemi I.T., Korenbrot C.C., Jaffe R.B. Content of chorionic gonadotropin in human fetal tissues. J Clin Endocrinol Metab 1978, 46:994.
53. McGregor W.G., Raymoure W.J., Kuhn R.W., et al. Fetal tissue can synthesize a placental hormone. Evidence for chorionic gonadotropin beta-subunit synthesis by human fetal kidney. J Clin Invest 1981, 68:306.
54. McGregor W.G., Kuhn R.W., Jaffe R.B. Biologically active chorionic gonadotropin: synthesis by the human fetus. Science 1983, 220:306.
55. Goldsmith P.C., McGregor W.G., Raymoure W.J., et al. Cellular localization of chorionic gonadotropin in human fetal kidney and liver. J Clin Endocrinol Metab 1983, 57:654.
56. Seeburg P.H., Adelman J.P. Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature 1984, 311:666.
57. Gibbons J.M., Mitnick M., Chieffo V. In vitro biosynthesis of TSH- and LH-releasing factors by the human placenta. Am J Obstet Gynecol 1975, 121:127.
58. Siler-Khodr T.M., Khodr G.S., Valenzuela G. Immunoreactive gonadotropin-releasing hormone level in maternal circulation throughout pregnancy. Am J Obstet Gynecol 1984, 150:376.
59. Currie A.J., Fraser H.M., Sharpe R.M. Human placental receptors for luteinizing hormone releasing hormone. Biochem Biophys Res Commun 1981, 99:332.
60. Rabinovici J., Goldsmith P.C., Librach C.L., et al. Localization and regulation of the activin-A dimer in human placental cells. J Clin Endocrinol Metab 1992, 75:571.
61. Petraglia F., Sawchenko P., Lim A.T., et al. Localization, secretion, and action of inhibin in human placenta. Science 1987, 237:187.
62. McLachlan R.I., Healy D.L., Lutjen P.J., et al. The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clin Endocrinol (Oxf) 1987, 27:663.
63. Muttukrishna S., Child T.J., Groome N.P., et al. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997, 12:1089.
64. Florio P., Cobellis L., Luisi S., et al. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001, 180:123.
65. Florio P., Luisi S., Ciarmela P., et al. Inhibins and activins in pregnancy. Mol Cell Endocrinol 2004, 225:93.
66. Petraglia F., Volpe A., Genazzani A., et al. Neuroendocrinology of the human placenta. Front Neuroendocrinol 1990, 11:6.
67. Petraglia F., Vaughan J., Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci U S A 1989, 86:5114.
68. Mersol-Barg M.S., Miller K.F., Choi C.M., et al. Inhibin suppresses human chorionic gonadotropin secretion in term, but not first trimester, placenta. J Clin Endocrinol Metab 1990, 71:1294.
69. Anthony R.V., Limesand S.W., Fanning M.D., et al. Placental lactogen and growth hormone. The Endocrinology of Pregnancy 1998, p 461. Humana Press, Totowa, NJ. F.W. Bazer (Ed.).
70. Ito Y., Higashi K. Studies on the prolactin-like substance in human placenta II. Endocrinol Jap 1961, 8:279.
71. Josimovich J.B., MacLaren J.A. Presence in the human placenta and term serum of a highly lactogenic substance immunologically related to pituitary growth hormone. Endocrinology 1962, 71:209.
72. Grumbach M.M., Kaplan S.L., Sciarra J.J., et al. Chorionic growth hormone-prolactin (CGP): secretion, disposition, biologic activity in man, and postulated function as the "growth hormone" of the 2d half of pregnancy. Ann N Y Acad Sci 1968, 148:501.
73. Crosignani P.G., Nencioni T., Brambati B. Concentration of chorionic gonadotrophin and chorionic somatomammotrophin in maternal serum, amniotic fluid and cord blood serum at term. J Obstet Gynaecol Br Commonw 1972, 79:122.
74. Kaplan S.L., Gurpide E., Sciarra J.J., et al. Metabolic clearance rate and production rate of chorionic growth hormone-prolactin in late pregnancy. J Clin Endocrinol Metab 1968, 28:1450.
75. Chen E.Y., Liao Y.C., Smith D.H., et al. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989, 4:479.
76. Hoshina M., Boothby M., Boime I. Cytological localization of chorionic gonadotropin alpha and placental lactogen mRNAs during development of the human placenta. J Cell Biol 1982, 93:190.
77. Friesen H.G., Suwa S., Pare P. Synthesis and secretion of placental lactogen and other proteins by the placenta. Recent Prog Horm Res 1969, 25:161.
78. Jeske W., Soszynski P., Rogozinski W., et al. Plasma GHRH, CRH, ACTH, beta-endorphin, human placental lactogen, GH and cortisol concentrations at the third trimester of pregnancy. Acta Endocrinol (Copenh) 1989, 120:785.
79. Kumasaka T., Nishi N., Yaoi Y., et al. Demonstration of immunoreactive somatostatin-like substance in villi and decidua in early pregnancy. Am J Obstet Gynecol 1979, 134:39.
80. Watkins W.B., Yen S.S. Somatostatin in cytotrophoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. J Clin Endocrinol Metab 1980, 50:969.
81. Kim Y.J., Felig P. Plasma chorionic somatomammotropin levels during starvation in midpregnancy. J Clin Endocrinol Metab 1971, 32:864.
82. Tyson J.E., Austin K., Farinholt J., et al. Endocrine-metabolic response to acute starvation in human gestation. Am J Obstet Gynecol 1976, 125:1073.
83. Hochberg Z., Perlman R., Brandes J.M., et al. Insulin regulates placental lactogen and estradiol secretion by cultured human term trophoblast. J Clin Endocrinol Metab 1983, 57:1311.
84. Cousins L., Rigg L., Hollingsworth D., et al. The 24-hour excursion and diurnal rhythm of glucose, insulin, and C-peptide in normal pregnancy. Am J Obstet Gynecol 1980, 136:483.
85. Gillmer M.D., Oakley N.W., Beard R.W., et al. Plasma human placental lactogen profiles over 24 hours in normal and diabetic pregnancy. Br J Obstet Gynaecol 1977, 84:197.
86. Handwerger S. Clinical counterpoint: the physiology of placental lactogen in human pregnancy. Endocr Rev 1991, 12:329.
87. Liebhaber S.A., Urbanek M., Ray J., et al. Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest 1989, 83:1985.
88. Frankenne F., Closset J., Gomez F., et al. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 1988, 66:1171.
89. Eriksson L., Frankenne F., Eden S., et al. Growth hormone 24-h serum profiles during pregnancy: lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989, 96:949.
90. Yen S.S., Vela P., Tsai C.C. Impairment of growth hormone secretion in response to hypoglycemia during early and late pregnancy. J Clin Endocrinol Metab 1970, 31:29.
91. Merimee T.J., Zapf J., Froesch E.R. Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf. J Clin Endocrinol Metab 1982, 54:1101.
92. Giampietro O., Ferdeghini M., Scatena P. Human placental lactogen (hPL) deficiency in a normal pregnancy. Postgrad Med J 1984, 60:689.
93. Rygaard K., Revol A., Esquivel-Escobedo D., et al. Absence of human placental lactogen and placental growth hormone (HGH-V) during pregnancy: PCR analysis of the deletion. Hum Genet 1998, 102:87.
94. Lacroix M.C., Guibourdenche J., Frendo J.L., et al. Human placental growth hormone: a review. Placenta 2002, 23(Suppl A). S87.
95. Alsat E., Guibourdenche J., Luton D., et al. Human placental growth hormone. Am J Obstet Gynecol 1997, 177:1526.
96. Josimovich J.B. Human placental lactogen: further evidence of placental mimicry of pituitary function. Am J Obstet Gynecol 1974, 120:550.
97. Lowman H.B., Cunningham B.C., Wells J.A. Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J Biol Chem 1991, 266:10982.
98. Kaplan S. Human chorionic somatomammotropin: secretion, biological effects and physiological significance. In Jaffe R (ed), The Endocrine Milieu of Pregnancy, Puerperium and Childhood: Report of the Third Ross Conference on Obstetric Research 1974, Ross Laboratories, Columbus, OH.
99. Samaan N., Yen S.C., Gonzalez D., et al. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968, 28:485.
100. Beck P., Daughaday W.H. Human placental lactogen: studies of its acute metabolic effects and disposition in normal man. J Clin Invest 1967, 46:103.
101. Riggi S.J., Boshart C.R., Bell P.H., et al. Some effects of purified placental protein (human) on lipid and carbohydrate metabolism. Endocrinology 1966, 79:709.
102. Chen C.L., Chang C.C., Krieger D.T., et al. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 1986, 118:2382.
103. Liotta A.S., Houghten R., Krieger D.T. Identification of a beta-endorphin-like peptide in cultured human placental cells. Nature 1982, 295:593.
104. Grigorakis S.I., Anastasiou E., Dai K., et al. Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term. Eur J Endocrinol 2000, 142:533.
105. Raffin-Sanson M.L., Massias J.F., Ankotche A., et al. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta. Clin Endocrinol (Oxf) 1999, 50:85.
106. Rees L.H., Burke C.W., Chard T., et al. Possible placental origin of ACTH in normal human pregnancy. Nature 1975, 254:620.
107. Goland R.S., Wardlaw S.L., Stark R.I., et al. Human plasma beta-endorphin during pregnancy, labor, and delivery. J Clin Endocrinol Metab 1981, 52:74.
108. 2. J Clin Endocrinol Metab 1979, 49:888.
109. Sastry B.V., Barnwell S.L., Tayeb O.S., et al. Occurrence of methionine enkephalin in human placental villus. Biochem Pharmacol 1980, 29:475.
110. Valette A., Desprat R., Cros J., et al. Immunoreactive dynorphine in maternal blood, umbilical vein and amniotic fluid. Neuropeptides 1986, 7:145.
111. Ahmed M.S., Horst M.A. Opioid receptors of human placental villi modulate acetylcholine release. Life Sci 1986, 39:535.
112. McLean M., Smith R. Corticotropin-releasing hormone in human pregnancy and parturition. Trends Endocrinol Metab 1999, 10:174.
113. Frim D.M., Emanuel R.L., Robinson B.G., et al. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988, 82:287.
114. Goland R.S., Wardlaw S.L., Stark R.I., et al. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986, 63:1199.
115. Goland R.S., Wardlaw S.L., Blum M., et al. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am J Obstet Gynecol 1988, 159:884.
116. McLean M., Bisits A., Davies J., et al. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1:460.
117. Hillhouse E.W., Grammatopoulos D.K. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006, 27:260.
118. Perrin M.H., Donaldson C.J., Chen R., et al. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133:3058.
119. Chen R., Lewis K.A., Perrin M.H., et al. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A 1993, 90:8967.
120. Perrin M., Donaldson C., Chen R., et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A 1995, 92:2969.
121. Petraglia F., Sutton S., Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989, 160:247.
122. Ni X., Chan E.C., Fitter J.T., et al. Nitric oxide inhibits corticotropin-releasing hormone exocytosis but not synthesis by cultured human trophoblasts. J Clin Endocrinol Metab 1997, 82:4171.
123. Korebrits C., Yu D.H., Ramirez M.M., et al. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol 1998, 105:556.
124. Marinoni E., Korebrits C., Di Iorio R., et al. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998, 178:770.
125. Robinson B.G., Emanuel R.L., Frim D.M., et al. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 1988, 85:5244.
126. King B., Smith R., Nicholson R. Novel glucocorticoid and cAMP interactions on the CRH gene promoter. Mol Cell Endocrinol 2002, 194:19.
127. Smith R., Mesiano S., Chan E.C., et al. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998, 83:2916.
128. Chakravorty A., Mesiano S., Jaffe R. Corticotropin-releasing hormone stimulates P450 17-a hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C. J Clin Endocrinol Metab 1999, 84:3732.
129. Ibanez L., Potau N., Marcos M.V., et al. Corticotropin-releasing hormone as adrenal androgen secretagogue. Pediatr Res 1999, 46:351.
130. Petraglia F., Sawchenko P.E., Rivier J., et al. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987, 328:717.
131. Plotsky P.M. Regulation of hypophysiotropic factors mediating ACTH secretion. Ann N Y Acad Sci 1987, 512:205.
132. Reis F.M., Petraglia F. The placenta as a neuroendocrine organ. Front Horm Res 2001, 27:216.
133. Petraglia F., Florio P., Gallo R., et al. Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 1996, 81:3807.
134. Petraglia F., Florio P., Benedetto C., et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 1999, 84:1420.
135. Reis F.M., Fadalti M., Florio P., et al. Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. J Soc Gynecol Investig 1999, 6:109.
136. Florio P., Vale W., Petraglia F. Urocortins in human reproduction. Peptides 2004, 25:1751.
137. Shambaugh G., Kubek M., Wilber J.F. Thyrotropin-releasing hormone activity in the human placenta. J Clin Endocrinol Metab 1979, 48:483.
138. Youngblood W.W., Humm J., Lipton M.A., et al. Thyrotropin-releasing hormone-like bioactivity in placenta: evidence for the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of stimulating pituitary thyrotropin release. Endocrinology 1980, 106:541.
139. Ahima R., Flier J. Leptin. Annu Rev Physiol 2000, 62:413.
140. Elmquist J.K. Anatomic basis of leptin action in the hypothalamus. Front Horm Res 2000, 26:21.
141. Moschos S., Chan J.L., Mantzoros C.S. Leptin and reproduction: a review. Fertil Steril 2002, 77:433.
142. Harris RB. Leptin: much more than a satiety signal. Annu Rev Nutr 2000, 20:45.
143. Senaris R., Garcia-Caballero T., Casabiell X., et al. Synthesis of leptin in human placenta. Endocrinology 1997, 138:4501.
144. Hardie L., Trayhurn P., Abramovich D., et al. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997, 47:101.
145. Tamura T., Goldenberg R.L., Johnston K.E., et al. Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstet Gynecol 1998, 91:389.
146. Henson M.C., Castracane V.D. Leptin in pregnancy. Biol Reprod 2000, 63:1219.
147. Tamas P., Sulyok E., Szabo I., et al. Changes of maternal serum leptin levels during pregnancy. Gynecol Obstet Invest 1998, 46:169.
148. Stock S.M., Bremme K.A. Elevation of plasma leptin levels during pregnancy in normal and diabetic women. Metabolism 1998, 47:840.
149. Akerman F., Lei Z.M., Rao C.V. Human umbilical cord and fetal membranes co-express leptin and its receptor genes. Gynecol Endocrinol 2002, 16:299.
150. Highman T.J., Friedman J.E., Huston L.P., et al. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998, 178:1010.
151. Mukherjea R., Castonguay T.W., Douglass L.W., et al. Elevated leptin concentrations in pregnancy and lactation: possible role as a modulator of substrate utilization. Life Sci 1999, 65:1183.
152. Hauguel-de Mouzon S., Lepercq J., Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006, 194:1537.
153. Chardonnens D., Cameo P., Aubert M.L., et al. Modulation of human cytotrophoblastic leptin secretion by interleukin-1alpha and 17beta-oestradiol and its effect on HCG secretion. Mol Hum Reprod 1999, 5:1077.
154. Jansson N., Greenwood S.L., Johansson B.R., et al. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab 2003, 88:1205.
155. Balasubramaniam A. Clinical potentials of neuropeptide Y family of hormones. Am J Surg 2002, 183:430.
156. DiBona G.F., Neuropeptide Y. Am J Physiol Regul Integr Comp Physiol 2002, 282:R635.
157. Petraglia F., Calza L., Giardino L., et al. Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites. Endocrinology 1989, 124:2016.
158. Dotsch J., Nusken K.D., Knerr I., et al. Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. J Clin Endocrinol Metab 1999, 84:2755.
159. Jang M., Mistry A., Swick A., et al. Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 2000, 130:2813.
160. Petraglia F., Coukos G., Battaglia C., et al. Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. J Clin Endocrinol Metab 1989, 69:324.
161. Robidoux J., Simoneau L., St-Pierre S., et al. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts. Endocrinology 2000, 141:2795.
162. Bowen J.M., Chamley L., Keelan J.A., et al. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 2002, 23:257.
163. Bowen J.M., Chamley L., Mitchell M.D., et al. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta 2002, 23:239.
164. Deal C.L., Guyda H.J., Lai W.H., et al. Ontogeny of growth factor receptors in the human placenta. Pediatr Res 1982, 16:820.
165. Constancia M., Hemberger M., Hughes J., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002, 417:945.
166. Crossey P.A., Pillai C.C., Miell J.P. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 2002, 110:411.
167. Wu H.K., Squire J.A., Song Q., et al. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochem Biophys Res Commun 1997, 233:221.
168. Carr B.R., Simpson E.R. Cholesterol synthesis in human fetal tissues. J Clin Endocrinol Metab 1982, 55:447.
169. Johansson E. Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) 1979, 61:607.
170. Jaffe R.B., Perez-Palacios G., Lamont K.G., et al. De novo steroid sulfate biosynthesis. J Clin Endocrinol Metab 1968, 28:1671.
171. Frandsen V.A., Stakeman G. The clinical significance of oestriol estimators in late pregnancy. Acta Endocrinol (Copenh) 1963, 44:183.
172. Goebelsmann U., Chen L.C., Saga M., et al. Plasma concentration and protein binding of oestriol and its conjugates in pregnancy. Acta Endocrinol (Copenh) 1973, 74:592.
173. Goebelsmann U., Jaffe R.B. Oestriol metabolism in pregnant women. Acta Endocrinol (Copenh) 1971, 66:679.
174. Yen S.S.C. Endocrine-metabolic adaptations in pregnancy. Reproductive Endocrinology 1991, p 936. WB Saunders, Philadelphia. S.S.C. Yen, R.B. Jaffe (Eds.).
175. Siiteri P.K., Febres F., Clemens L.E., et al. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant?. Ann N Y Acad Sci 1977, 286:384.
176. Perusquia M. Nongenomic action of steroids in myometrial contractility. Endocrine 2001, 15:63.
177. Chanrachakul B., Pipkin F.B., Warren A.Y., et al. Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium. Am J Obstet Gynecol 2005, 192:458.
178. Lofgren M., Holst J., Backstrom T. Effects in vitro of progesterone and two 5 alpha-reduced progestins, 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one, on contracting human myometrium at term. Acta Obstet Gynecol Scand 1992, 71:28.
179. Perusquia M., Garcia-Yanez E., Ibanez R., et al. Non-genomic mechanism of action of delta-4 and 5-reduced androgens and progestins on the contractility of the isolated rat myometrium. Life Sci 1990, 47:1547.
180. Perusquia M., Jasso-Kamel J. Influence of 5 alpha- and 5 beta-reduced progestins on the contractility of isolated human myometrium at term. Life Sci 2001, 68:2933.
181. Pinto R.M., Lerner U., Pontelli H. The effect of progesterone on oxytocin-induced contraction of the three separate layers of human gestational myometrium in the uterine body and lower segment. Am J Obstet Gynecol 1967, 98:547.
182. Fu X., Rezapour M., Lofgren M., et al. Unexpected stimulatory effect of progesterone on human myometrial contractile activity in vitro. Obstet Gynecol 1993, 82:23.
183. Fu X., Rezapour M., Lofgren M., et al. Antitachyphylactic effects of progesterone and oxytocin on term human myometrial contractile activity in vitro. Obstet Gynecol 1993, 82:532.
184. Rezapour M., Hongpaisan J., Fu X., et al. Effects of progesterone and oxytocin on intracellular elemental composition of term human myometrium in vitro. Eur J Obstet Gynecol Reprod Biol 1996, 68:191.
185. 2+ homeostasis in human myometrial smooth muscle cells. Am J Physiol 1999, 276:C379.
186. Kofinas A.D., Rose J.C., Koritnik D.R., et al. Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity. J Reprod Med 1990, 35:1045.
187. Sager G., Orbo A., Jaeger R., et al. Non-genomic effects of progestins: inhibition of cell growth and increased intracellular levels of cyclic nucleotides. J Steroid Biochem Mol Biol 2003, 84:1.
188. Karteris E., Zervou S., Pang Y., et al. Progesterone signaling in human myometrium through two novel membrane G protein coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 2006.
189. Bogacki M., Silvia W.J., Rekawiecki R., et al. Direct inhibitory effect of progesterone on oxytocin-induced secretion of prostaglandin F(2alpha) from bovine endometrial tissue. Biol Reprod 2002, 67:184.
190. Dunlap K.A., Stormshak F. Nongenomic inhibition of oxytocin binding by progesterone in the ovine uterus. Biol Reprod 2004, 70:65.
191. Grazzini E., Guillon G., Mouillac B., et al. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998, 392:509.
192. Sergeev P.V., Sizov P.I., Dukhanin A.S., et al. [Study of the GABA-benzodiazepine receptor system of the human myometrium]. Biull Eksp Biol Med 1990, 110:382.
193. Hendricks C.H., Brenner W.E., Gabel R.A., et al. The effect of progesterone administered intra-amniotically in late human pregnancy. In Barnes AC (ed), Progesterone 1961, Brook Lodge Press, Augusta, MI.
194. Pinto R.M., Montuori E., Lerner U., et al. Effect of progesterone on the oxytocic action of estradiol-17-beta. Am J Obstet Gynecol 1965, 91:1084.
195. da Fonseca E.B., Bittar R.E., Carvalho M.H., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003, 188:419.
196. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348:2379.
197. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:687.
198. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007, 357:454.
199. DeFranco E.A., O'Brien J.M., Adair C.D., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved
200. Thornton J.G. Progesterone and preterm labor: still no definite answers. N Engl J Med 2007, 357:499.
201. Grumbach M.M. Estrogen insensitivity and deficiency in the human. In Proceedings of the 80th Endocrine Society. New Orleans, The Endocrine Society, Abstract S21-1 1998.
202. Resnik R., Killam A.P., Battaglia F.C., et al. The stimulation of uterine blood flow by various estrogens. Endocrinology 1974, 94:1192.
203. Pepe G.J., Albrecht E.D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995, 16:608.
204. Yang K. Placental 11ß hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod 1997, 2:129.
205. Mitchell B.F., Seron-Ferre M., Jaffe R.B. Cortisol-cortisone interrelationship in the late gestation rhesus monkey fetus in utero. Endocrinology 1982, 111:1837.
206. Mitchell B.F., Seron-Ferre M., Hess D.L., et al. Cortisol production and metabolism in the late gestation rhesus monkey fetus. Endocrinology 1981, 108:916.
207. Seckl J.R. Glucocorticoids and small babies. Q J Med 1994, 87:259.
208. Seckl J.R., Benediktsson R., Lindsay R.S., et al. Placental 11ß-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol 1995, 55:447.
209. Burton P.J., Waddell B.J. Dual function of 11ß-hydroxysteroid dehydrogenase in placenta: modulating placenta glucocorticoid passage and local steroid action. Biol Reprod 1999, 60:234.
210. Huhtaniemi I.T., Koritnik D.R., Korenbrot C.C., et al. Stimulation of pituitary-testicular function with gonadotropin-releasing hormone in fetal and infant monkeys. Endocrinology 1979, 105:109.
211. Rasmussen D.D., Liu J.H., Wolf P.L., et al. Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro. J Clin Endocrinol Metab 1983, 57:881.
212. Kaplan S.L., Grumbach M.M., Aubert M.L. The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function. Recent Prog Horm Res 1976, 32:161.
213. Bresson J.L., Clavequin M.C., Fellmann D., et al. Ontogeny of the neuroglandular system revealed with HPGRF 44 antibodies in human hypothalamus. Neuroendocrinology 1984, 39:68.
214. Blumenfeld Z., Jaffe R.B. Hypophysiotropic and neuromodulatory regulation of adrenocorticotropin in the human fetal pituitary gland. J Clin Invest 1986, 78:288.
215. Bugnon C., Fellmann D., Gouget A., et al. Corticoliberin neurons: Cytophysiology, phylogeny and ontogeny. J Steroid Biochem 1984, 20:183.
216. Bresson J.L., Clavequin M.C., Fellmann D., et al. Human corticoliberin hypothalamic neuroglandular system: comparative immunocytochemical study with anti-rat and anti-ovine corticotropin-releasing factor sera in the early stages of development. Brain Res 1987, 429:241.
217. Ackland J.F., Ratter S.J., Bourne G.L., et al. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami. J Endocrinol 1986, 108:171.
218. Nobin A., Bjorklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl 1973, 388:1.
219. McNeilly A.S., Gilmore D., Dobbie G., et al. Prolactin releasing activity in the early human foetal hypothalamus. J Endocrinol 1977, 73:533.
220. Baker B.L., Jaffe R.B. The genesis of cell types in the adenohypophysis of the human fetus as observed with immunocytochemistry. Am J Anat 1975, 143:137.
221. Sucheston M., Cannon M. Development of zonular patterns in the human adrenal gland. J Morphol 1968, 126:477.
222. Spencer S.J., Mesiano S., Lee J.Y., et al. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab 1999, 84:1110.
223. Mesiano S., Coulter C., Jaffe R. Localization of cytochrome P450 cholesterol side chain cleavage, cytchrome P450 17a-hydroxylase/17,20-lyase, and 3ß-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in the human and rhesus fetal adrenal gland: reappraisal of functional zonation. J Clin Endocrinol Metab 1992, 77:1184.
224. Benirschke K., Bloch E., Hertig A. Concerning the function of the fetal zone of the human adrenal gland. Endocrinology 1956, 58:598.
225. Mesiano S., Mellon S.H., Gospodarowicz D., et al. Basic fibroblast growth factor expression is regulated by ACTH in the human fetal adrenal: a model for adrenal growth regulation. Proc Natl Acad Sci U S A 1991, 88:5428.
226. Burris T., Guo W., McCabe E. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the superfamily. Rec Prog Horm Res 1996, 51:241.
227. Luo X., Ikeda Y., Parker K. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481.
228. 14C]-progesterone by the previable human fetus. J Steroid Biochem 1977, 8:499.
229. Doody K.M., Carr B.R., Rainey W.E., et al. 3ß-hydroxysteroid dehydrogenase/isomerase in the fetal zone and neocortex of the human fetal adrenal gland. Endocrinology 1990, 126:2487.
230. Coulter C.L., Goldsmith P.C., Mesiano S., et al. Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3 beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology 1996, 137:4953.
231. Bayard F., Ances I., Tapper A., et al. Transplacental passage and fetal secretion of aldosterone. J Clin Invest 1970, 49:1389.
232. Nelson H., Kuhn R., Deyman M., et al. Human fetal adrenal definitive and fetal zone metabolism of pregnenolone and corticosterone: alternate biosynthetic pathways and absence of detectable aldosterene synthesis. J Clin Endocrinol Metab 1990, 70:693.
233. Serón-Ferré M., Biglieri E.G., Jaffe R.B. Regulation of mineralocorticoid secretion by the superfused fetal monkey adrenal gland: lack of stimulation of aldosterone by ACTH. J Devel Physiol 1990, 13:33.
234. 2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation. J Clin Endocrinol Metab 1996, 81:3914.
235. Rabinovici J., Goldsmith P.C., Roberts V.J., et al. Localization and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab 1991, 73:1141.
236. Reyes F.I., Boroditsky R.S., Winter J.S., et al. Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. J Clin Endocrinol Metab 1974, 38:612.
237. Siiteri P.K., Wilson J.D. Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 1974, 38:113.
238. Pelliniemi L.J., Niei M. Fine structure of the human foetal testis. I. The interstitial tissue. Z Zellforsch Mikrosk Anat 1969, 99:507.
239. Gondos B., Westergaard L., Byskov A.G. Initiation of oogenesis in the human fetal ovary: ultrastructural and squash preparation study. Am J Obstet Gynecol 1986, 155:189.
240. Rabinovici J., Jaffe R.B. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 1990, 11:532.
241. Baker T.G., Scrimgeour J.B. Development of the gonad in normal and anencephalic human fetuses. J Reprod Fertil 1980, 60:193.
242. Lammie A., Drobnjak M., Gerald W., et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994, 42:1417.
243. Carlsson I.B., Laitinen M.P., Scott J.E., et al. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reproduction 2006, 131:641.
244. Skinner M.K. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005, 11:461.
245. Gulyas B.J., Hodgen G.D., Tullner W.W., et al. Effects of fetal or maternal hypophysectomy on endocrine organs and body weight in infant rhesus monkeys (. Macaca mulatta): with particular emphasis on oogenesis. Biol Reprod 1977, 16:216.
246. Huhtaniemi I.T., Yamamoto M., Ranta T., et al. Follicle-stimulating hormone receptors appear earlier in the primate fetal testis than in the ovary. J Clin Endocrinol Metab 1987, 65:1210.
247. Serra G.B., Perez-Palacios G., Jaffe R.B. De novo testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1970, 30:128.
248. Rice B.F., Johanson C.A., Sternberg W.H. Formation of steroid hormones from acetate-1-14C by a human fetal testis preparation grown in organ culture. Steroids 1966, 7:79.
249. Huhtaniemi I.T., Korenbrot C.C., Seron-Ferre M., et al. Stimulation of testosterone production in vivo and in vitro in the male rhesus monkey fetus in late gestation. Endocrinology 1977, 100:839.
250. Carr B.R., Parker C.R., Ohashi M., et al. Regulation of human fetal testicular secretion of testosterone: low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am J Obstet Gynecol 1983, 146:241.
251. Voutilainen R., Miller W.L. Developmental expression of genes for the stereoidogenic enzymes P450scc (20,22-desmolase), P450c17 (17 alpha-hydroxylase/17,20-lyase), and P450c21 (21-hydroxylase) in the human fetus. J Clin Endocrinol Metab 1986, 63:1145.
252. Tapanainen J., Voutilainen R., Jaffe R.B. Low aromatase activity and gene expression in human fetal testes. J Steroid Biochem 1989, 33:7.
253. George F.W., Wilson J.D. Conversion of androgen to estrogen by the human fetal ovary. J Clin Endocrinol Metab 1978, 47:550.
254. Fisher D.A., Klein A.H. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 1981, 304:702.
255. Melmed S., Harada A., Murata Y., et al. Fetal response to thyrotropin-releasing hormone after thyroid hormone administration to the rhesus monkey: lack of pituitary suppression. Endocrinology 1979, 105:334.
256. Jacobsen B.B., Andersen H., Dige-Petersen H., et al. Thyrotropin response to thyrotropin-releasing hormone in fullterm, euthyroid and hypothyroid newborns. Acta Paediatr Scand 1976, 65:433.
257. Fisher D.A., Dussault J.H., Sack J., et al. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 1976, 33:59.
258. Osathanondh R., Chopra I.J., Tulchinsky D. Effects of dexamethasone on fetal and maternal thyroxine, triiodothyronine, reverse triiodothyronine, and thyrotropin levels. J Clin Endocrinol Metab 1978, 47:1236.
259. Isaac R.M., Hayek A., Standefer J.C., et al. Reverse tri-iodothyronine to tri-iodothyronine ratio and gestational age. J Pediatr 1979, 94:477.
260. 3) in the human newborn. J Clin Invest 1975, 55:1137.
261. Abuid J., Stinson D.A., Larsen P.R. Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery. J Clin Invest 1973, 52:1195.
262. DeGroot L.J., Robertson M., Rue P.A. Triiodothyronine receptors during maturation. Endocrinology 1977, 100:1511.
263. Schwartz H.L., Oppenheimer J.H. Ontogenesis of 3,5,3'-triiodothyronine receptors in neonatal rat brain: dissociation between receptor concentration and stimulation of oxygen consumption by 3,5,3'-triiodothyronine. Endocrinology 1978, 103:943.
264. Walker P., Weichsel M.E., Fisher D.A., et al. Thyroxine increases nerve growth factor concentration in adult mouse brain. Science 1979, 204:427.
265. Mulchahey J.J., DiBlasio A.M., Martin M.C., et al. Hormone production and peptide regulation of the human fetal pituitary gland. Endocr Rev 1987, 8:406.
266. Grumbach M.M., Gluckman P.D. The human fetal hypothalamus and pituitary gland: the maturation of neuroendocrine mechanisms controlling secretion of fetal pituitary growth hormone, prolactin, gonadotropins, adrenaocorticotropin-related peptides and thyrotropin. Maternal-Fetal Endocrinology 1994, p 193. WB Saunders, Philadelphia. ed 2. D. Tulchinsky, A.B. Little (Eds.).
267. Goodyer C.G., Sellen J.M., Fuks M., et al. Regulation of growth hormone secretion from human fetal pituitaries: interactions between growth hormone releasing factor and somatostatin. Reprod Nutr Dev 1987, 27:461.
268. Barker D.J. The developmental origins of chronic adult disease. Acta Paediatr Suppl 2004, 93:26.
269. Barker D.J. The developmental origins of adult disease. J Am Coll Nutr 2004, 23:588S.
270. Barker D.J., Winter P.D., Osmond C., et al. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577.
271. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077.
272. Ravelli A.C., van der Meulen J.H., Michels R.P., et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998, 351:173.
273. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005, 85:571.
274. Gluckman P.D., Hanson M.A., Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005, 1:130.
275. Gluckman P.D., Hanson M.A., Spencer H.G. Predictive adaptive responses and human evolution. Trends Ecol Evol 2005, 20:527.
276. Gluckman P.D., Hanson M.A. Metabolic disease: evolutionary, developmental and transgenerational influences. Nestle Nutr Workshop Ser Pediatr Program 2005, 55:17.
277. Rehman K.S., Sirianni R., Parker C.R., et al. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells. Reprod Sci 2007, 14:578.
278. Bloomfield F.H., Oliver M.H., Hawkins P., et al. Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology 2004, 145:4278.
279. Challis J.R.G., Lye S.J. Parturition. The Physiology of Reproduction 1994, p 985. Raven Press, New York. E. Knobil, J.D. Neil (Eds.).
280. Liggins G. The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev 1994, 6:141.
281. Liggins G. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969, 45:515.
282. Price H.V., Cone B.R., Keogh M. Length of gestation in congenital adrenal hyperplasia. J Obstet Gynecol Br Comm 1971, 78:430.
283. Patrick J.E., Challis J.R.G., Natale R., et al. Circadian rhythms in maternal plasma cortisol, estrone, estradiol and estriol at 34 to 35 weeks' gestation. Am J Obstet Gynecol 1979, 135:791.
284. Casey M.L., Macdonald P.C. Endocrine changes of pregnancy. Williams Textbook of Endocrinology 1998, p 1259. WB Saunders, Philadelphia. J.D. Wilson, D.W. Foster, H.M. Kronenberg (Eds.).
285. Corner G.W. The Hormones in Human Reproduction 1946, Princeton University Press, London.
286. Csapo A. Progesterone "block". Am J Anat 1956, 98:273.
287. Liggins G.C., Fairclough R.J., Grieves S.A., et al. The mechanism of initiation of parturition in the ewe. Rec Prog Horm Res 1973, 29:111.
288. Liggins G.C. Endocrinology of parturition. Fetal Endocrinology 1981, p 211. Academic Press, New York. M.J. Novy, J.A. Resko (Eds.).
289. Thorburn G.D., Challis J.R. Endocrine control of parturition. Physiol Rev 1979, 59:863.
290. Thorburn G.D., Hollingworth S.A., Hooper S.B. The trigger for parturition in sheep: fetal hypothalamus or placenta?. J Dev Physiol 1991, 15:71.
291. Flint A.P.P., Anderson A.B.M., Steele P.A., et al. The mechanism by which foetal cortisol controls the onset of parturition in the sheep. Biochem Soc Trans 1975, 3:1189.
292. Jasper D.E. Prolonged gestation in the bovine. Cornell Vet 1950, 40:165.
293. Kennedy P.C., Kendrick J.W., Stormont C. Adenohypophyseal aplasia, an inherited defect associated with abnormal gestation in guernsey cattle. Cornell Vet 1957, 47:160.
294. Malpas P. Postmaturity and malformations of the fetus. J Obstet Gynecol Br Emp 1933, 40:1046.
295. Benirschke K. Adrenals in anencephaly and hydrocephaly. Obstet Gynecol 1956, 8:412.
296. Honnebier W., Swaab D. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J Obstet Gynaecol Br Comm 1973, 80:577.
297. Conneely O.M., Lydon J.P. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids 2000, 65:571.
298. Giangrande P.H., McDonnell D.P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog Horm Res 1999, 54:291.
299. Tung L., Mohamed M.K., Hoeffler J.P., et al. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 1993, 7:1256.
300. Vegeto E., Shahbaz M.M., Wen D.X., et al. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993, 7:1244.
301. Merlino A.A., Welsh T.N., Tan H., et al. Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J Clin Endocrinol Metab 2007, 92:1927.
302. Mesiano S., Chan E.C., Fitter J.T., et al. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002, 87:2924.
303. Pieber D., Allport V.C., Hills F., et al. Interaction between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 2001, 7:875.
304. Henderson D., Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset. Am J Obstet Gynecol 2001, 185:579.
305. Condon J.C., Jeyasuria P., Faust J.M., et al. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 2003, 100:9518.
306. Dong X., Shylnova O., Challis J.R., et al. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem 2005, 280:13329.
307. Mecenas C., Giussani D., Owiny J., et al. Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion. Nat Med 1996, 2:443.
308. Nathanielsz P.W., Jenkins S.L., Tame J.D., et al. Local paracrine effects of estradiol are central to parturition in the rhesus monkey. Nat Med 1998, 4:456.
309. Gustafsson J.A. An update on estrogen receptors. Semin Perinatol 2000, 24:66.
310. Madsen G., Zakar T., Ku C.Y., et al. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal. J Clinl Endocrinol Metabol 2004, 89:1010.
311. Jain J.K., Mishell D.R. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994, 331:290.
312. Robins J., Mann L.I. Midtrimester pregnancy termination by intramuscular injection of a 15-methyl analogue of prostaglandin F2 alpha. Am J Obstet Gynecol 1975, 123:625.
313. Mitchell M.D., Romero R.J., Edwin S.S., et al. Prostaglandins and parturition. Reprod Fertil Dev 1995, 7:623.
314. Thomson A.J., Telfer J.F., Young A., et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999, 14:229.
315. Andrews W.W., Hauth J.C., Goldenberg R.L. Infection and preterm birth. Am J Perinatol 2000, 17:357.
316. Boggess K.A. Pathophysiology of preterm birth: emerging concepts of maternal infection. Clin Perinatol 2005, 32:561.
317. Goldenberg R.L., Culhane J.F. Infection as a cause of preterm birth. Clin Perinatol 2003, 30:677.
318. Sanchez A.R., Kupp L.I., Sheridan P.J., et al. Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 2004, 6:89.
319. Jeffcoat M.K., Geurs N.C., Reddy M.S., et al. Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc 2001, 132:875.
320. Barnes C.M. Treatment of periodontal disease and the risk of preterm birth. Pract Proced Aesthet Dent 2007, 19:118.
321. Goldenberg R.L., Culhane J.F. Preterm birth and periodontal disease. N Engl J Med 2006, 355:1925.
322. Gravett M.G., Witkin S.S., Haluska G.J., et al. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994, 171:1660.
323. Romero R., Mazor M., Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991, 165:969.
324. Bloom S.L., Yost N.P., McIntire D.D., et al. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol 2001, 98:379.
325. Elliott J.P. Preterm labor in twins and high-order multiples. Obstet Gynecol Clin North Am 2005, 32:429.
326. Shynlova O., Tsui P., Dorogin A., et al. The expression of transforming growth factor beta in pregnant rat myometrium is hormone and stretch dependent. Reproduction 2007, 134:503.
327. Shynlova O., Williams S.J., Draper H., et al. Uterine stretch regulates temporal and spatial expression of fibronectin protein and its alpha 5 integrin receptor in myometrium of unilaterally pregnant rats. Biol Reprod 2007, 77(5):880.
328. Shynlova O.P., Oldenhof A.D., Liu M., et al. Regulation of c-fos expression by static stretch in rat myometrial smooth muscle cells. Am J Obstet Gynecol 2002, 186:1358.
329. Dalrymple A., Mahn K., Poston L., et al. Mechanical stretch regulates TRPC expression and calcium entry in human myometrial smooth muscle cells. Mol Hum Reprod 2007, 13(3):171.
330. Loudon J.A., Sooranna S.R., Bennett P.R., et al. Mechanical stretch of human uterine smooth muscle cells increases IL-8 mRNA expression and peptide synthesis. Mol Hum Reprod 2004, 10:895.
331. Mitchell J.A., Shynlova O., Langille B.L., et al. Mechanical stretch and progesterone differentially regulate activator protein-1 transcription factors in primary rat myometrial smooth muscle cells. Am J Physiol Endocrinol Metab 2004, 287:E439.
332. Oldenhof A.D., Shynlova O.P., Liu M., et al. Mitogen-activated protein kinases mediate stretch-induced c-fos mRNA expression in myometrial smooth muscle cells. Am J Physiol Cell Physiol 2002, 283:C1530.
333. Terzidou V., Sooranna S.R., Kim L.U., et al. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab 2005, 90:237.
334. Smith R., Wickings E., Bowman M., et al. Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies. J Clin Endocrinol Metab 1999, 84:2820.
335. Grammatopoulos D., Dai Y., Chen J., et al. Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 1998, 83:2539.
336. Grammatopoulos D., Hillhouse E.W. Solubilization and biochemical characterization of the human myometrial corticotrophin-releasing hormone receptor. Mol Cell Endocrinol 1998, 138:185.
337. Grammatopoulos D.K. The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labour. Front Biosci 2007, 12:561.
338. Jin D., He P., You X., et al. Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. Reprod Sci 2007, 14:568.
339. Jones S.A., Challis J.R. Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obstet Invest 1990, 29:165.
340. Jones S.A., Challis J.R. Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem Biophys Res Commun 1989, 159:192.
341. Quartero H.W., Noort W.A., Fry C.H., et al. Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRH) on the contraction force in human gestational myometrium. Prostaglandins 1991, 42:137.
342. Quartero H.W., Fry C.H. Placental corticotrophin releasing factor may modulate human parturition. Placenta 1989, 10:439.
343. Benedetto C., Petraglia F., Marozio L., et al. Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. Am J Obstet Gynecol 1994, 171:126.
344. Grammatopoulos D., Stirrat G.M., Williams S.A., et al. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab 1996, 81:745.
345. Thiery J. Induction of labor with prostaglandins. Human Parturition 1979, 155. Martinus Nijhoff, The Hague. M. Keirse, A. Anderson, J. Benebroek-Gravenhorst (Eds.).
346. Embrey M. PGE compounds for induction of labor and abortion. Ann N Y Acad Sci 1971, 180:518.
347. Collins E., Turner G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet 1975, 2:335.
348. Lewis R.B., Schulman J.D. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973, 2:1159.
349. Slater D., Dennes W., Sawdy R., et al. Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. J Mol Endocrinol 1999, 22:125.
350. Okazaki T., Casey M.L., Okita J.R., et al. Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am J Obstet Gynecol 1981, 139:373.
351. Challis J.R., Sloboda D.M., Alfaidy N., et al. Prostaglandins and mechanisms of preterm birth. Reproduction 2002, 124:1.
352. Zakar T., Hertelendy F. Regulation of prostaglandin synthesis in the human uterus. J Matern Fetal Med 2001, 10:223.
353. Slater D.M., Zervou S., Thornton S. Prostaglandins and prostanoid receptors in human pregnancy and parturition. J Soc Gynecol Investig 2002, 9:118.
354. Challis J. Mechanism of parturition and preterm labor. Obstet Gynecol Surv 2000, 55:650.
355. Gibb W. The role of prostaglandins in human parturition. Ann Med 1998, 30:235.
356. Challis J.R., Lye S.J., Gibb W. Prostaglandins and parturition. Ann N Y Acad Sci 1997, 828:254.
357. Kelly R.W. Inflammatory mediators and parturition. Rev Reprod 1996, 1:89.
358. Olson D.M., Mijovic J.E., Sadowsky D.W. Control of human parturition. Semin Perinatol 1995, 19:52.
359. Whittle W.L., Patel F.A., Alfaidy N., et al. Glucocorticoid regulation of human and ovine parturition: the relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production. Biol Reprod 2001, 64:1019.
360. Patel F.A., Challis J.R. Prostaglandins and uterine activity. Front Horm Res 2001, 27:31.
361. Challis J.R., Patel F.A., Pomini F. Prostaglandin dehydrogenase and the initiation of labor. J Perinat Med 1999, 27:26.
362. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994, 46:205.
363. Grigsby P.L., Sooranna S.R., Adu-Amankwa B., et al. Regional expression of prostaglandin E2 and F2 alpha receptors in human myometrium, amnion, and choriodecidua with advancing gestation and labor. Biol Reprod 2006, 75:297.
364. Matsumoto T., Sagawa N., Yoshida M., et al. The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are down-regulated during pregnancy. Biochem Biophys Res Commun 1997, 238:838.
365. Senior J., Marshall K., Sangha R., et al. In vitro characterization of prostanoid receptors on human myometrium at term. Br J Pharmacol 1993, 108:501.
366. Abramovitz M., Adam M., Boie Y., et al. Human prostanoid receptors: cloning and characterization. Adv Prostaglandin Thromboxane Leukot Res 1995, 23:499.
367. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta 1995, 1259:109.
368. Kotani M., Tanaka I., Ogawa Y., et al. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 1995, 48:869.
369. Brodt-Eppley J., Myatt L. Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 1999, 93:89.
370. Chibbar R., Miller F.D., Mitchell B.F. Synthesis of oxytocin in amnion, chorion and decidua may influence the timing of human parturition. J Clin Invest 1993, 91:185.
371. Fuchs A.R., Romero R., Keefe D., et al. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 1991, 165:1515.
372. Fisher D.A. Maternal-fetal neurohypophyseal system. Clin Perinatol 1983, 10:695.
373. Chard T. Fetal and maternal oxytocin in human parturition. Am J Perinatol 1989, 6:145.
374. Romero R., Sibai B.M., Sanchez-Ramos L., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000, 182:1173.
375. Goodwin T.M., Valenzuela G., Silver H., et al. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996, 13:143.
376. Fuchs A.R., Fuchs F., Husslein P., et al. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 1982, 215:1396.
377. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12:731.
378. Catalano P.M., Hollenbeck C. Energy requirements in pregnancy: a review. Obstet Gynecol Surv 1992, 47:368.
379. Challis J.R.G., Matthews S.G., Gibb W., et al. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000, 21:514.
380. Diedrich K., Fauser B.C., Devroey P., et al. The role of the endometrium and embryo in human implantation. Hum Reprod Update 2007, 13:365.
381. Giudice L.C. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 1994, 61:1.
382. Gluckman P.D., Hanson M.A., Pinal C. The developmental origins of adult disease. Matern Child Nutr 2005, 1:130.
383. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993, 68:495.
384. Hertelendy F., Zakar T. Regulation of myometrial smooth muscle functions. Curr Pharm Des 2004, 10:2499.
385. Keelan J.A., Blumenstein M., Helliwell R.J., et al. Cytokines, prostaglandins and parturition: a review. Placenta 2003, 24(Suppl A). S33.
386. Kliman H.J. Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. Am J Pathol 2000, 157:1759.
387. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997, 18:378.
388. Rabinovici J., Jaffe R.B. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 1990, 11:532.